These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22990096)

  • 1. Circulating vitamin D metabolites and kidney disease in type 1 diabetes.
    de Boer IH; Sachs MC; Cleary PA; Hoofnagle AN; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B; Brunzell JD;
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4780-8. PubMed ID: 22990096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    de Boer IH;
    Diabetes Care; 2014; 37(1):24-30. PubMed ID: 24356594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.
    Molitch ME; Steffes M; Sun W; Rutledge B; Cleary P; de Boer IH; Zinman B; Lachin J;
    Diabetes Care; 2010 Jul; 33(7):1536-43. PubMed ID: 20413518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
    DCCT/EDIC research group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):793-800. PubMed ID: 25043685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
    de Boer IH; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B; Brunzell JD; ; White NH; Danis RP; Davis MD; Hainsworth D; Hubbard LD; Nathan DM
    Arch Intern Med; 2011 Mar; 171(5):412-20. PubMed ID: 21403038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Glomerular Hyperfiltration and Long-Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience.
    Molitch ME; Gao X; Bebu I; de Boer IH; Lachin J; Paterson A; Perkins B; Saenger AK; Steffes M; Zinman B;
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):854-861. PubMed ID: 31123181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.
    de Boer IH; Sachs MC; Chonchol M; Himmelfarb J; Hoofnagle AN; Ix JH; Kremsdorf RA; Lin YS; Mehrotra R; Robinson-Cohen C; Siscovick DS; Steffes MW; Thummel KE; Tracy RP; Wang Z; Kestenbaum B
    Am J Kidney Dis; 2014 Aug; 64(2):187-97. PubMed ID: 24703961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
    de Boer IH; Gao X; Cleary PA; Bebu I; Lachin JM; Molitch ME; Orchard T; Paterson AD; Perkins BA; Steffes MW; Zinman B;
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1969-1977. PubMed ID: 27797889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    JAMA; 2003 Oct; 290(16):2159-67. PubMed ID: 14570951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
    ; de Boer IH; Sun W; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Zinman B
    N Engl J Med; 2011 Dec; 365(25):2366-76. PubMed ID: 22077236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.
    de Boer IH; Sibley SD; Kestenbaum B; Sampson JN; Young B; Cleary PA; Steffes MW; Weiss NS; Brunzell JD;
    J Am Soc Nephrol; 2007 Jan; 18(1):235-43. PubMed ID: 17151331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetes.
    Sachs MC; Brunzell JD; Cleary PA; Hoofnagle AN; Lachin JM; Molitch ME; Steffes MW; Zinman B; de Boer IH;
    Diabetes Care; 2013 Aug; 36(8):2423-9. PubMed ID: 23530012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal outcomes in patients with type 1 diabetes and macroalbuminuria.
    de Boer IH; Afkarian M; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B;
    J Am Soc Nephrol; 2014 Oct; 25(10):2342-50. PubMed ID: 24925722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study.
    Costacou T; Ellis D; Fried L; Orchard TJ
    Am J Kidney Dis; 2007 Nov; 50(5):721-32. PubMed ID: 17954285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Kidney Disease in Type 1 Diabetes.
    Perkins BA; Bebu I; de Boer IH; Molitch M; Tamborlane W; Lorenzi G; Herman W; White NH; Pop-Busui R; Paterson AD; Orchard T; Cowie C; Lachin JM;
    Diabetes Care; 2019 May; 42(5):883-890. PubMed ID: 30833370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.
    Bjornstad P; Wiromrat P; Johnson RJ; Sippl R; Cherney DZI; Wong R; Rewers MJ; Snell-Bergeon JK
    Diabetes Care; 2019 Feb; 42(2):297-302. PubMed ID: 30482755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes.
    Perkins BA; Rabbani N; Weston A; Ficociello LH; Adaikalakoteswari A; Niewczas M; Warram J; Krolewski AS; Thornalley P
    PLoS One; 2012; 7(4):e35655. PubMed ID: 22558190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
    Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes.
    Klein RL; Hammad SM; Baker NL; Hunt KJ; Al Gadban MM; Cleary PA; Virella G; Lopes-Virella MF;
    Metabolism; 2014 Oct; 63(10):1287-95. PubMed ID: 25088746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between low glomerular filtration rate, hypertension, and microalbuminuria in type 1 diabetes mellitus].
    Vasović O; Zamaklar M; Lalić K; Milosević D; Zikić L; Popović L; Ozegović J; Rajković N; Dragković D
    Vojnosanit Pregl; 2005 May; 62(5):349-55. PubMed ID: 15913038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.